Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC
| Image |  |
|---|---|
| Description | scientific article published on 27 August 2019 |
| Author/s |
author: John V Heymach Lixia Diao |
| Publication date | August 27, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |